AstraZeneca releases positive Phase 2 COVID-19 vaccine data, says Phase 3 data available by Christmas

AstraZeneca and Oxford University on Thursday released data showing positive results of their Phase II COVID-19 vaccine trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.